MedTrace Logo

Observational Study to Reduce Medication Errors

NCT01734642 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 8000

Last updated 2012-11-29

No results posted yet for this study

Summary

A medication error is a failure in the treatment process that leads to, or has the potential to lead, to harm to the patient.1 Medication errors are a common unfortunate occurrence in hospital. They can occur in different phases of the therapeutic process (prescribing, distribution, administration and monitoring) and have significant impact on morbidity and mortality. Prescribing faults and prescription errors are major problem among medication errors .Prescription errors account for 70 % of medication errors that could potentially result in adverse drug effects.2 Overall it has been estimated prescription errors affect 7 % of medication orders, 2% of patient days and 50 % of hospital admissions.3,4 When harm arises from a medication error it is potentially preventable. The medication errors project was devised to analyze and limit through educational audit and other tools, as much as possible, damages due to the therapeutic process. The project will include 5 phases. Preliminary phase: organizational meetings. Phase I: Patient monitoring: a monitor in collaboration with health professionals of involved units will review all patient charts and will register all adverse drug reactions(ADRs). All ADRs will be introduced by the monitor in a database. Health professional will be invited to send the reports of observed ADRs. Evaluation of ADRs : a panel of experts will evaluate if the ADRs are due to medication errors or not. Phase II :educational audits directed to health professionals will be organized. Tools to reduce the medication errors will be proposed. Phase III: the same procedure of the first phase. Final phase (IV): analysis of data with publication of a scientific article.

Conditions

  • Medication Errors

Sponsors & Collaborators

  • Ospedale S.Bortolo -Vicenza, Italy

    collaborator UNKNOWN

  • Ospedale Mater Salutis-Legnago(Verona), Italy

    collaborator UNKNOWN

  • Ospedale Fra Castoro- San Bonifacio (Verona), Italy

    collaborator UNKNOWN

  • Azienda Ospedaliera Universitaria Integrata Verona

    collaborator OTHER

  • Universita di Verona

    lead OTHER

Principal Investigators

  • Giampaolo Velo, Medicine and Surgery · The University of Verona, Verona , Italy

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2013-11-30
Completion
2013-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01734642 on ClinicalTrials.gov